TransCure bioServices

About:

TransCure bioServices provides predictive, preclinical R&D expertise via its services to the pharmaceutical and biotechnology industry.

Website: http://www.transcurebioservices.com/

Twitter/X: _TransCure

Top Investors: Venture Kick, EASME - EU Executive Agency for SMEs, Arbevel

Description:

TransCure bioServices has developped unique Research & Development (R&D) platforms, called the Humanized Immune System (HIS) and Human Immunodeficiency Virus (HIV) mouse models. They provide access to these platforms as a fee-for-service for the pharmaceutical companies, biotechs as well as academic laboratories which profile new drugs targeting immuno-related diseases and novel anti-HIV/AIDS therapies.

Total Funding Amount:

$3.97M

Headquarters Location:

Carouge, Geneve, Switzerland

Founded Date:

2012-01-01

Contact Email:

info(AT)tcbiosciences.com

Founders:

Patrick Nef

Number of Employees:

1-10

Last Funding Date:

2019-06-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai